Starch Medical

5 articles about Starch Medical

• Starch Medical Inc. European Patent Issued

  11/7/2018

  Starch Medical a privately held manufacturer and marketer of polysaccharide based hemostatic products for use in controlling bleeding in surgery and trauma applications has announced the issuance of European Patent Number 2203053 for MODIFIED STARCH MATERIAL OF BIOCOMPATIBLE HEMOSTASIS.

• Starch Medical Inc. Expands Hemostasis Portfolio With Launch of SuperClot

  11/7/2017

  Next week Starch Medical will exhibit and hold distributor meetings at MEDICA the world's leading trade fair for the medical industry held in Düsseldorf, Germany from November 13-16, 2017.

• CryoLife, Inc. Enters into Worldwide Distribution and Manufacturing Agreements with Starch Medical for Novel Hemostatic Agent

  9/29/2010

• Starch Medical Launches Advanced Laparoscopic Hemostat

  4/29/2009

• Starch Medical Launches New, Bioinert Surgical Hemostats

  12/2/2008